Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

- PMLiVE

GSK gets maintenance indication for Trelegy

Will now treat airflow obstruction in COPD patients

Roche Basel Switzerland

Ocrevus helps Roche stave off biosimilar threat

Its low price strategy for the CD20-targeting antibody is paying off

- PMLiVE

ABPI explores the future of medicines

Predicts inhalable nanobots and 3D printed medicine patches

- PMLiVE

Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more

A rapid round up of pharma, biotech and healthcare news

- PMLiVE

Shire warms to Takeda’s latest offer, extending deadline

The new offer is £5 per share higher than Takeda’s opening bid

- PMLiVE

Otsuka finally gets FDA OK for kidney disease drug

Approval at last for rare disease treatment

- PMLiVE

Pfizer takes aim at UK’s health tech industry

Offers start-ups a share of a £56k grant

Shire Basingstoke

Morning brief: Takeda closes in on $64bn merger, GSK unveils team, and more

A rapid run-down of news in pharma, biotech and healthcare

It’s nice, but it’s not an infographic

If you want to know if you’ve created an infographic, you can have a go with our flow diagram

Cuttsy + Cuttsy

- PMLiVE

PureTech Health appoints new chief financial officer

Joep Muijrers joins the biopharma from Life Sciences Partners

Uncertainty, austerity and Brexit

What does it mean for the life science sector?

Pharma’s isolated islands of innovation

With service design and technology often failing the patient, why perspective on improving outcomes need to change

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links